Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H16N3O6S.Na |
Molecular Weight | 329.305 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C([O-])=O
InChI
InChIKey=QWXDICNEPRTOLR-GEMLJDPKSA-M
InChI=1S/C10H17N3O6S.Na/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16;/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19);/q;+1/p-1/t5-,6-;/m0./s1
Molecular Formula | C10H16N3O6S |
Molecular Weight | 306.316 |
Charge | -1 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/23036594 |
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ef475c9-7938-4870-b336-fb0c2dafb3cd | https://clinicaltrials.gov/ct2/show/NCT01450267
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/23036594 |
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ef475c9-7938-4870-b336-fb0c2dafb3cd | https://clinicaltrials.gov/ct2/show/NCT01450267
Glutathione (GSH, also called as reduced glutathione) is a tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes such as, glutathione reductase, glutathione peroxidases, peroxiredoxins. Glutathione S-transferases catalyse the conjugation of GSH via a sulfhydryl group to electrophilic centers on a wide variety of substrates in order to make the compounds more water-soluble. As a part of homeopathic product, glutathione is used for temporary relief of symptoms related to Free Radical Toxicity including tingling in hands and feet, mood changes, frequent colds, poor digestion, fatigue, and constipation. In addition, for temporary relief of pain in the back from urinating, constant urging and frequent urination, kidneys sensitive to pressure, and pain from back extending down the thigh. Glutathione is an important nutrient for brain function and loss of glutathione has been implicated in Parkinson's disease. In phase II of the clinical trial was investigated whether administration of either dose of glutathione, as a nasal spray, improves PD symptoms over time in a population of individuals with Parkinson's disease (PD). In addition in phase II of clinical trial was shown, that reduced glutathione, an ingredient of RayGel™, has been helpful in decreasing some radiation therapy side effects to the skin. Reduced glutathione plays a vital role in both making DNA and cell repair. Cystic fibrosis (CF) is the most common inherited disease among the Caucasian population with considerable morbidity and reduced life expectancy. Glutathione (GSH) represents the first-line defence of the lung against oxidative stress-induced cell injury. Therapeutic approaches with inhaled GSH could improve the reduced lung antioxidant capacity in order to counterbalance the oxidant stress linked to the chronic airway inflammation and bacterial infection.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Glutathione S-transferases Sources: https://www.ncbi.nlm.nih.gov/pubmed/4436301 |
|||
Target ID: P00390 Gene ID: 2936.0 Gene Symbol: GSR Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/23036594 |
|||
Target ID: Glutathione peroxidases Sources: https://www.ncbi.nlm.nih.gov/pubmed/23036594 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
CD95-Mediated murine hepatic apoptosis requires an intact glutathione status. | 1999 Jul |
|
Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa. | 1999 Jun 1 |
|
Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells. | 2000 Apr 14 |
|
Mitochondrial adaptations to obesity-related oxidant stress. | 2000 Jun 15 |
|
The catalytic Tyr-9 of glutathione S-transferase A1-1 controls the dynamics of the C terminus. | 2000 Jun 9 |
|
Detection of phosphorylation-dependent interactions by far-western gel overlay. | 2001 |
|
Assays for mitogen-activated protein kinase (MAPK) subtypes and MAPK activating protein kinase-2 (MAPKAP K-2) using a common cell lysate. | 2001 |
|
Nitrogen monoxide (no) and glucose: unexpected links between energy metabolism and no-mediated iron mobilization from cells. | 2001 Feb 16 |
|
Expression of gamma-glutamyl transpeptidase protects ramos B cells from oxidation-induced cell death. | 2001 Feb 9 |
|
Effects of phenytoin on glutathione status and oxidative stress biomarker gene mRNA levels in cultured precision human liver slices. | 2001 Jan |
|
The activity of NF-kappaB in Swiss 3T3 cells exposed to aqueous extracts of cigarette smoke is dependent on thioredoxin. | 2001 Jan |
|
Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites? | 2001 Jan |
|
Dual effects of nitric oxide in functional and regressing rat corpus luteum. | 2001 Jan |
|
Greater susceptibility of failing cardiac myocytes to oxygen free radical-mediated injury. | 2001 Jan |
|
Single amino acid changes outside the active site significantly affect activity of glutathione S-transferases. | 2001 Jan |
|
The intracellular oxidation of 2',7'-dichlorofluorescin in murine T lymphocytes. | 2001 Jan 1 |
|
Thiols can either enhance or suppress DNA damage induction by catecholestrogens. | 2001 Jan 1 |
|
Differential effects of bcl-2 on cell death triggered under ATP-depleting conditions. | 2001 Jan 1 |
|
Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion. | 2001 Jan 10 |
|
Catalase in astroglia-rich primary cultures from rat brain: immunocytochemical localization and inactivation during the disposal of hydrogen peroxide. | 2001 Jan 12 |
|
In vitro binding of ribosomes to the beta subunit of the Sec61p protein translocation complex. | 2001 Jan 26 |
|
Inhibition of adenylate cyclase activity by 5-aminolevulinic acid in rat and human brain. | 2001 Mar |
|
A proteome analysis of the cadmium response in Saccharomyces cerevisiae. | 2001 Mar 16 |
|
Glutathione stimulates sulfated estrogen transport by multidrug resistance protein 1. | 2001 Mar 2 |
|
The cytosolic O-acetylserine(thiol)lyase gene is regulated by heavy metals and can function in cadmium tolerance. | 2001 Mar 23 |
|
gamma -glutamyltransferase and its isoform mediate an endoplasmic reticulum stress response. | 2001 Mar 23 |
|
A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission. | 2001 Mar 30 |
|
Structural properties and mechanisms that govern association of C kinase adapter 1 with protein kinase C3 and the cell periphery. | 2001 Mar 30 |
|
A direct inhibitory role for the Rab3-specific effector, Noc2, in Ca2+-regulated exocytosis in neuroendocrine cells. | 2001 Mar 30 |
|
Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein. | 2001 Mar 9 |
|
Zinc release from the CH2C6 zinc finger domain of FILAMENTOUS FLOWER protein from Arabidopsis thaliana induces self-assembly. | 2001 Mar 9 |
|
The putative glutathione peroxidase gene of Plasmodium falciparum codes for a thioredoxin peroxidase. | 2001 Mar 9 |
|
A genetic investigation of the essential role of glutathione: mutations in the proline biosynthesis pathway are the only suppressors of glutathione auxotrophy in yeast. | 2001 Mar 9 |
|
Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B. | 2001 Mar 9 |
Patents
Sample Use Guides
For temporary relief of symptoms related to Free Radical Toxicity: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
pain in the back from urinating: 10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
Breast Cancer: RayGel Topical Cream applied in thin layer to the area exposed to radiation 60-90 minutes prior to radiotherapy, standard skin care between treatments.
Cystic Fibrosis: Inhaled Reduced Glutathione 10 mg/kg, twice daily, 12 months
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 03:01:48 GMT 2023
by
admin
on
Sat Dec 16 03:01:48 GMT 2023
|
Record UNII |
H0X6UKX533
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
H0X6UKX533
Created by
admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
|
PRIMARY | |||
|
100000078214
Created by
admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
|
PRIMARY | |||
|
SUB76116
Created by
admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
|
ALTERNATIVE | |||
|
SUB13991MIG
Created by
admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
|
PRIMARY | |||
|
92043348
Created by
admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
|
PRIMARY | |||
|
DTXSID90955757
Created by
admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
|
PRIMARY | |||
|
34212-83-4
Created by
admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
20167-21-9
Created by
admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
|
PRIMARY | |||
|
251-884-1
Created by
admin on Sat Dec 16 03:01:49 GMT 2023 , Edited by admin on Sat Dec 16 03:01:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |